Stock listing
OTC:MDNAF Medicenna Therapeutics Corp. Stock
US listing (OTC) of Medicenna Therapeutics Corp. · home listing TSX:MDNA
Follow Medicenna Therapeutics Corp. into a list and get an email when it puts out news.
Share price · OTC:MDNAF
$0.31 USD -0.00 (-0.4%)
Close on Oct 27, 2026
- Day range
- $0.31 – $0.31 USDOct 27, 2026
- Volume
- 15,000 sharesOct 27, 2026
- Market cap
- $28.61M USDAt the close on Oct 27, 2026 · price × 92.30M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSX:MDNA · Home | $0.425 CAD | -0.030 (-6.6%) | 30,489 | $0.435 | $0.435 | $0.425 | $0.455 | Close on Nov 2, 2026 |
| OTC:MDNAF | $0.31 USD | -0.001 (-0.4%) | 15,000 | $0.31 | $0.31 | $0.31 | $0.311 | Close on Oct 27, 2026 |
- Ticker
- OTC:MDNAF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Oct 26, 2026
Medicenna Reports Potent CD122 Blockade and Extended Survival with MDNA209 in Preclinical Models of Autoimmune Disease
Latest deck · September 2026
HC Wainwright 28th Annual Global Investment Conference 2026
Conference · 27 slides
Latest news
Decks
HC Wainwright 28th Annual Global Investment Conference 2026
Conference · 27 slides · September 2026
ESMO-IO Congress 2025
Conference · 27 slides · Dec 10, 2025
Investor Presentation (October 2025)
Investor deck · 24 slides · October 2025
Corporate Update (August 2022)
Corporate update · 10 slides · Aug 15, 2022
Medicenna Therapeutics Corp. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 28 in the last 12 months · 143 in all · newest Oct 26, 2026 · oldest 2017
- Decks
- 5 decks · latest September 2026
Where Medicenna Therapeutics Corp. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSX:MDNA · Home listing | TSX | Canada | CAD |
| OTC:MDNAF · This page | OTC | United States | USD |
| Cboe Canada:MDNA | Cboe Canada | Canada | CAD |
Log in to ask 6ix AI your own questions about Medicenna Therapeutics Corp.